Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques

Dallit Mannheim, Joerg Herrmann, Daniele Versari, Mario Gössl, Fredric B. Meyer, Joseph P. McConnell, Lilach O Lerman, Amir Lerman

Research output: Contribution to journalArticle

122 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE-: Circulating lipoprotein-associated phospholipase A2 (Lp-PLA2) has emerged as a novel biomarker for cardiovascular diseases. However, the correlation between the plaque expression of Lp-PLA2 and plaque oxidative stress, inflammation, and stability as well as the clinical presentation remains poorly defined, especially for cerebrovascular disease. Therefore, this study was performed to test the hypothesis that Lp-PLA2 expression is higher in symptomatic than in asymptomatic carotid plaques of patients undergoing carotid endarterectomy. METHODS-: The expression of Lp-PLA2 in 167 carotid artery plaques was determined by immunoblotting and immunostaining. Plaque oxidative stress, inflammation, and stability were quantified by NAD(P)H oxidase p67phox and MMP-2 immunoblotting, oxidized LDL (oxLDL) immunoreactivity, macrophage and Sirius red collagen staining. Lysophosphatidylcholine 16:0 (lysoPC) concentration was measured in 55 plaques using liquid chromatography tandem mass spectrometry. RESULTS-: Lp-PLA2 expression was significantly higher in plaques of symptomatic patients than asymptomatic patients (1.66±0.19 versus 1.14±0.10, P<0.05) and localized mainly to shoulder and necrotic lipid core areas in colocalization with oxLDL and macrophage content. Similarly, Lp-PLA2 expression was related to collagen content, which was lower in plaques from symptomatic patients than in plaques from asymptomatic patients (9.1±2.2 versus 18.5±1.7% of staining/field, P<0.001). LysoPC plaque concentration was significantly higher in plaques of symptomatic than asymptomatic patients (437.0±57.91 versus 228.84±37.00 mmol/L, P<0.05). CONCLUSIONS-: Symptomatic carotid artery plaques are characterized by increased levels of Lp-PLA2 and its product lysoPC in correlation with markers of tissue oxidative stress, inflammation, and instability. These findings strongly support a role for Lp-PLA2 in the pathophysiology and clinical presentation of cerebrovascular disease.

Original languageEnglish (US)
Pages (from-to)1448-1455
Number of pages8
JournalStroke
Volume39
Issue number5
DOIs
StatePublished - May 1 2008

Fingerprint

1-Alkyl-2-acetylglycerophosphocholine Esterase
Lysophosphatidylcholines
Atherosclerotic Plaques
Cerebrovascular Disorders
Oxidative Stress
Carotid Stenosis
Inflammation
Immunoblotting
Collagen
Macrophages
Staining and Labeling
Carotid Endarterectomy
NADPH Oxidase
Tandem Mass Spectrometry
Matrix Metalloproteinases
Liquid Chromatography
Lipoproteins
Cardiovascular Diseases
Biomarkers
Lipids

Keywords

  • Atherosclerosis
  • Carotid
  • Lp-PLA2
  • Lysophosphatidylcholine
  • Unstable plaque

ASJC Scopus subject areas

  • Medicine(all)
  • Cardiology and Cardiovascular Medicine
  • Clinical Neurology
  • Advanced and Specialized Nursing

Cite this

Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques. / Mannheim, Dallit; Herrmann, Joerg; Versari, Daniele; Gössl, Mario; Meyer, Fredric B.; McConnell, Joseph P.; Lerman, Lilach O; Lerman, Amir.

In: Stroke, Vol. 39, No. 5, 01.05.2008, p. 1448-1455.

Research output: Contribution to journalArticle

Mannheim, Dallit ; Herrmann, Joerg ; Versari, Daniele ; Gössl, Mario ; Meyer, Fredric B. ; McConnell, Joseph P. ; Lerman, Lilach O ; Lerman, Amir. / Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques. In: Stroke. 2008 ; Vol. 39, No. 5. pp. 1448-1455.
@article{a6da4d1d14734ed4b50bbaa406648017,
title = "Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques",
abstract = "BACKGROUND AND PURPOSE-: Circulating lipoprotein-associated phospholipase A2 (Lp-PLA2) has emerged as a novel biomarker for cardiovascular diseases. However, the correlation between the plaque expression of Lp-PLA2 and plaque oxidative stress, inflammation, and stability as well as the clinical presentation remains poorly defined, especially for cerebrovascular disease. Therefore, this study was performed to test the hypothesis that Lp-PLA2 expression is higher in symptomatic than in asymptomatic carotid plaques of patients undergoing carotid endarterectomy. METHODS-: The expression of Lp-PLA2 in 167 carotid artery plaques was determined by immunoblotting and immunostaining. Plaque oxidative stress, inflammation, and stability were quantified by NAD(P)H oxidase p67phox and MMP-2 immunoblotting, oxidized LDL (oxLDL) immunoreactivity, macrophage and Sirius red collagen staining. Lysophosphatidylcholine 16:0 (lysoPC) concentration was measured in 55 plaques using liquid chromatography tandem mass spectrometry. RESULTS-: Lp-PLA2 expression was significantly higher in plaques of symptomatic patients than asymptomatic patients (1.66±0.19 versus 1.14±0.10, P<0.05) and localized mainly to shoulder and necrotic lipid core areas in colocalization with oxLDL and macrophage content. Similarly, Lp-PLA2 expression was related to collagen content, which was lower in plaques from symptomatic patients than in plaques from asymptomatic patients (9.1±2.2 versus 18.5±1.7{\%} of staining/field, P<0.001). LysoPC plaque concentration was significantly higher in plaques of symptomatic than asymptomatic patients (437.0±57.91 versus 228.84±37.00 mmol/L, P<0.05). CONCLUSIONS-: Symptomatic carotid artery plaques are characterized by increased levels of Lp-PLA2 and its product lysoPC in correlation with markers of tissue oxidative stress, inflammation, and instability. These findings strongly support a role for Lp-PLA2 in the pathophysiology and clinical presentation of cerebrovascular disease.",
keywords = "Atherosclerosis, Carotid, Lp-PLA2, Lysophosphatidylcholine, Unstable plaque",
author = "Dallit Mannheim and Joerg Herrmann and Daniele Versari and Mario G{\"o}ssl and Meyer, {Fredric B.} and McConnell, {Joseph P.} and Lerman, {Lilach O} and Amir Lerman",
year = "2008",
month = "5",
day = "1",
doi = "10.1161/STROKEAHA.107.503193",
language = "English (US)",
volume = "39",
pages = "1448--1455",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques

AU - Mannheim, Dallit

AU - Herrmann, Joerg

AU - Versari, Daniele

AU - Gössl, Mario

AU - Meyer, Fredric B.

AU - McConnell, Joseph P.

AU - Lerman, Lilach O

AU - Lerman, Amir

PY - 2008/5/1

Y1 - 2008/5/1

N2 - BACKGROUND AND PURPOSE-: Circulating lipoprotein-associated phospholipase A2 (Lp-PLA2) has emerged as a novel biomarker for cardiovascular diseases. However, the correlation between the plaque expression of Lp-PLA2 and plaque oxidative stress, inflammation, and stability as well as the clinical presentation remains poorly defined, especially for cerebrovascular disease. Therefore, this study was performed to test the hypothesis that Lp-PLA2 expression is higher in symptomatic than in asymptomatic carotid plaques of patients undergoing carotid endarterectomy. METHODS-: The expression of Lp-PLA2 in 167 carotid artery plaques was determined by immunoblotting and immunostaining. Plaque oxidative stress, inflammation, and stability were quantified by NAD(P)H oxidase p67phox and MMP-2 immunoblotting, oxidized LDL (oxLDL) immunoreactivity, macrophage and Sirius red collagen staining. Lysophosphatidylcholine 16:0 (lysoPC) concentration was measured in 55 plaques using liquid chromatography tandem mass spectrometry. RESULTS-: Lp-PLA2 expression was significantly higher in plaques of symptomatic patients than asymptomatic patients (1.66±0.19 versus 1.14±0.10, P<0.05) and localized mainly to shoulder and necrotic lipid core areas in colocalization with oxLDL and macrophage content. Similarly, Lp-PLA2 expression was related to collagen content, which was lower in plaques from symptomatic patients than in plaques from asymptomatic patients (9.1±2.2 versus 18.5±1.7% of staining/field, P<0.001). LysoPC plaque concentration was significantly higher in plaques of symptomatic than asymptomatic patients (437.0±57.91 versus 228.84±37.00 mmol/L, P<0.05). CONCLUSIONS-: Symptomatic carotid artery plaques are characterized by increased levels of Lp-PLA2 and its product lysoPC in correlation with markers of tissue oxidative stress, inflammation, and instability. These findings strongly support a role for Lp-PLA2 in the pathophysiology and clinical presentation of cerebrovascular disease.

AB - BACKGROUND AND PURPOSE-: Circulating lipoprotein-associated phospholipase A2 (Lp-PLA2) has emerged as a novel biomarker for cardiovascular diseases. However, the correlation between the plaque expression of Lp-PLA2 and plaque oxidative stress, inflammation, and stability as well as the clinical presentation remains poorly defined, especially for cerebrovascular disease. Therefore, this study was performed to test the hypothesis that Lp-PLA2 expression is higher in symptomatic than in asymptomatic carotid plaques of patients undergoing carotid endarterectomy. METHODS-: The expression of Lp-PLA2 in 167 carotid artery plaques was determined by immunoblotting and immunostaining. Plaque oxidative stress, inflammation, and stability were quantified by NAD(P)H oxidase p67phox and MMP-2 immunoblotting, oxidized LDL (oxLDL) immunoreactivity, macrophage and Sirius red collagen staining. Lysophosphatidylcholine 16:0 (lysoPC) concentration was measured in 55 plaques using liquid chromatography tandem mass spectrometry. RESULTS-: Lp-PLA2 expression was significantly higher in plaques of symptomatic patients than asymptomatic patients (1.66±0.19 versus 1.14±0.10, P<0.05) and localized mainly to shoulder and necrotic lipid core areas in colocalization with oxLDL and macrophage content. Similarly, Lp-PLA2 expression was related to collagen content, which was lower in plaques from symptomatic patients than in plaques from asymptomatic patients (9.1±2.2 versus 18.5±1.7% of staining/field, P<0.001). LysoPC plaque concentration was significantly higher in plaques of symptomatic than asymptomatic patients (437.0±57.91 versus 228.84±37.00 mmol/L, P<0.05). CONCLUSIONS-: Symptomatic carotid artery plaques are characterized by increased levels of Lp-PLA2 and its product lysoPC in correlation with markers of tissue oxidative stress, inflammation, and instability. These findings strongly support a role for Lp-PLA2 in the pathophysiology and clinical presentation of cerebrovascular disease.

KW - Atherosclerosis

KW - Carotid

KW - Lp-PLA2

KW - Lysophosphatidylcholine

KW - Unstable plaque

UR - http://www.scopus.com/inward/record.url?scp=44449157784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44449157784&partnerID=8YFLogxK

U2 - 10.1161/STROKEAHA.107.503193

DO - 10.1161/STROKEAHA.107.503193

M3 - Article

C2 - 18356547

AN - SCOPUS:44449157784

VL - 39

SP - 1448

EP - 1455

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 5

ER -